BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 34 found
  Current Search:  amitiza: 34     

HTML
100%
Media Advisory: New Amitiza (lubiprostone) and Irritable Bowel Syndrome with Constipation Data Presented at th
New data on the efficacy of AMITIZA 8 mcg, twice daily, and impact of irritable bowel syndrome with constipation (IBS-C) on employment and cost figures will be presented in poster format at the American College of Gastroenterology 2008...
Pharma Live:  Oct 7 2008 5:09PM
Matching: amitiza
Find similar documents
HTML
100%
MEDIA ADVISORY: New AMITIZA(R) (lubiprostone) and Irritable Bowel Syndrome with Constipation Data Presented at
New data on the efficacy of AMITIZA 8 mcg, twice daily, and impact of irritable bowel syndrome with constipation (IBS-C) on employment and cost figures will be presented in poster format at the American College of Gastroenterology 2008...
Calibre Macro World:  Oct 6 2008 10:52PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Announces Positive Results from a Japanese Phase 2b Dose-Ranging Study of AMITIZA for
- (NewsRx.com) -- (NASDAQ: SCMP) announced results of its phase 2b dose-ranging study of AMITIZA(R) (lubiprostone) in patients with Chronic Idiopathic Constipation (CIC), conducted in Japan.

The study demonstrated a statistically...

Macro World Investor:  Oct 3 2008 1:51AM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Announces Positive Results from a Japanese Phase 2b Dose-Ranging Study of AMITIZA for
- (NewsRx.com) -- (NASDAQ: SCMP) announced results of its phase 2b dose-ranging study of AMITIZA(R) (lubiprostone) in patients with Chronic Idiopathic Constipation (CIC), conducted in Japan.

The study demonstrated a statistically...

Calibre Macro World:  Oct 3 2008 1:46AM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Announces Positive Results from a Japanese Phase 2b Dose-Ranging Study of AMITIZA for
_ Sucampo Pharmaceuticals Announces Positive Results from a Japanese Phase 2b Dose-Ranging Study of AMITIZA for.
Evergreen Investments:  Oct 3 2008 3:27AM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Invites Investors to Listen to Webcast of Presentation at UBS Conference
- Sucampo Pharmaceuticals, Inc.

(NASDAQ:SCMP) today announced that its presentation at the UBS Global Life Sciences Conference will be webcast and may be accessed at www.sucampo.com A member of Sucampo Pharmaceuticals Investors interested...

DiGiTAL50:  Sep 24 2008 7:01AM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo announces positive phase 2b study of Amitiza
Sucampo Pharmaceuticals, Inc announced results of its phase-2b dose-ranging study of Amitiza (lubiprostone) in patients with Chronic Idiopathic Constipation (CIC), conducted in Japan.

The study demonstrated a statistically...

PharmaBiz:  Sep 23 2008 1:01PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Invites Investors to Listen to Webcast of Presentation at UBS Conference
A member of Sucampo Pharmaceuticals Investors interested in listening to the live webcast should log on before the start time in order to download any software required.

The archive of the webcast will be available for several days after...

Business Wire:  Sep 23 2008 8:41PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Invites Investors to Listen to Webcast of Presentation at UBS Conference
BETHESDA, MD--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc.

(NASDAQ:SCMP - News) today announced that its presentation at the UBS Global Life Sciences Conference will be webcast and may be accessed at www.sucampo.com A member of Sucampo...

Yahoo! Canada:  Sep 23 2008 8:32PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Invites Investors to Listen to Webcast of Presentation at UBS Conference
BETHESDA, MD - (Business Wire) Sucampo Pharmaceuticals, Inc.

(NASDAQ:SCMP) today announced that its presentation at the UBS Global Life Sciences Conference will be webcast and may be accessed at www.sucampo.com A member of Sucampo...

Earthtimes.org:  Sep 23 2008 8:30PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Invites Investors to Listen to Webcast of Presentation at UBS Conference
BETHESDA, MD -- (Business Wire) Sucampo Pharmaceuticals, Inc.

(NASDAQ:SCMP) today announced that its presentation at the UBS Global Life Sciences Conference will be webcast and may be accessed at www.sucampo.com A member of Sucampo...

Stockwatch:  Sep 23 2008 8:27PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Invites Investors to Listen to Webcast of Presentation at UBS Conference
Sucampo Pharmaceuticals, (News) Inc.

(NASDAQ:SCMP) today announced that its presentation at the UBS Global Life Sciences Conference will be webcast and may be accessed at www.sucampo.com A member of Sucampo Pharmaceuticals' Investors...

FinanzNachrichten.de:  Sep 23 2008 8:22PM
Matching: amitiza
Find similar documents
HTML
100%
22 Sep 08 | Sucampo reports positive results from Phase IIb constipation trial
results from Phase IIb constipation trial Sucampo Pharmaceuticals, a biopharmaceutical company, has announced positive results of its Phase IIb dose-ranging study of Amitiza in patients with chronic idiopathic constipation conducted in...
PharmiWeb:  Sep 22 2008 10:35PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Announces Positive Results from a Japanese Phase 2b Dose-Ranging Study of AMITIZA for
BETHESDA, MD--(BUSINESS WIRE)--Sept.

18, 2008 - Sucampo Pharmaceuticals, Inc.

(NASDAQ: SCMP) today announced results of its phase 2b dose-ranging study of AMITIZA(R) (lubiprostone) in patients with Chronic Idiopathic Constipation (CIC),...

Pharma Live:  Sep 20 2008 3:00AM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo reports positive results from Phase IIb constipation trial
The study has demonstrated a statistically significant increase in mean change in spontaneous bowel movements (SBM) from baseline after one week on treatment (p<0.0001), the study's primary endpoint, for patients taking Amitiza 24...
Pharmaceutical Business Review:  Sep 20 2008 11:52AM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Announces Positive Results from a Japanese Phase 2b Dose-Ranging Study of AMITIZA(R) f
Sucampo Pharmaceuticals, Inc.

(NASDAQ: SCMP) today announced results of its phase 2b dose-ranging study of AMITIZA(R) (lubiprostone) in patients with Chronic Idiopathic Constipation (CIC), conducted in Japan.

The study demonstrated a...

Genetic Engineering News:  Sep 18 2008 10:25PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Announces Positive Results from a Japanese Phase 2b Dose-Ranging Study of AMITIZA(R) f
BETHESDA, MD--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc.

(NASDAQ: SCMP - News) today announced results of its phase 2b dose-ranging study of AMITIZA (lubiprostone) in patients with Chronic Idiopathic Constipation (CIC), conducted...

Yahoo! Canada:  Sep 18 2008 8:28PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Announces Positive Results from a Japanese Phase 2b Dose-Ranging Study of AMITIZA(R) f
- Sucampo Pharmaceuticals, Inc.

(NASDAQ: SCMP) today announced results of its phase 2b dose-ranging study of AMITIZA AMITIZA 24 mcg also demonstrated statistically significant improvement versus placebo for several secondary...

DiGiTAL50:  Sep 19 2008 6:36AM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Announces Positive Results from a Japanese Phase 2b Dose-Ranging Study of AMITIZA(R) f
Sucampo Pharmaceuticals, (News) Inc.

(NASDAQ: SCMP) today announced results of its phase 2b dose-ranging study of AMITIZA AMITIZA 24 mcg also demonstrated statistically significant improvement versus placebo for several...

FinanzNachrichten.de:  Sep 18 2008 8:45PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Announces Positive Results from a Japanese Phase 2b Dose-Ranging Study of AMITIZA(R) f
BETHESDA, MD--(BUSINESS WIRE)--Sept.

18, 2008 - Sucampo Pharmaceuticals, Inc.

(NASDAQ: SCMP) today announced results of its phase 2b dose-ranging study of AMITIZA(R) (lubiprostone) in patients with Chronic Idiopathic Constipation (CIC),...

Pharma Live:  Sep 19 2008 12:48PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Announces Positive Results from a Japanese Phase 2b Dose-Ranging Study of AMITIZA(R) f
- Sucampo Pharmaceuticals, Inc.

Kate de Santis, 240-223-3834 or Westwicke Partners, LLC John Woolford, 410-321-9653 John.Woolford@westwickepartners.com Sucampo Pharmaceuticals, Inc.

(NASDAQ: SCMP) today announced results of its phase 2b...

PR inside:  Sep 19 2008 12:47AM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Announces Positive Results from a Japanese Phase 2b Dose-Ranging Study of AMITIZA(R) f
BETHESDA, MD--(BUSINESS WIRE)-- Sucampo Pharmaceuticals, Inc.

(NASDAQ: SCMP) today announced results of its phase 2b dose-ranging study of AMITIZA(R) (lubiprostone) in patients with Chronic Idiopathic Constipation (CIC), conducted in Japan...

Street Insider:  Sep 18 2008 8:33PM
Matching: amitiza
Find similar documents
HTML
100%
GlowWorm Builds Executive Ranks
AGENCY SEES GROWTH IN CONSUMER HEALTH MARKETING NEW YORK, Sept.

18, 2008 Seeing opportunities in the fast changing consumer healthcare marketing arena, Glow Worm announced that it has hired Mark Drossman as EVP, Executive Creative Director...

Pharma Live:  Sep 18 2008 5:42PM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo names new board member
Dr Dolecek is currently Sucampo's senior vice president of R&D.

Dr Dolecek has received his BS from the University of Maryland and a MPH in health services and planning from the University of Hawaii.

Ryuji Ueno, chairman and CEO of...

Pharmaceutical Business Review:  Aug 29 2008 8:54AM
Matching: amitiza
Find similar documents
HTML
100%
Sucampo Pharmaceuticals Strengthens Its Board of Directors
BETHESDA, MD--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc.

(NASDAQ:SCMP - News) today announced that Gayle Dolecek, P.D., M.P.H., has been appointed to its Board of Directors.

Dolecek is currently Sucampos Senior Vice President of...

Business Wire via Yahoo!:  Aug 27 2008 8:28PM
Matching: amitiza
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.